Skip to content

The Archive · A Source

Diagnostyka Reports 33% Growth in Recurring EBITDA in 2024

Diagnostyka Group 2025 grupadiagnostyka.pl/en/diagnostyka-reports-33-growth-in-recurring-ebitda-in-2024